Stay updated with breaking news from Raymond stevens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Although its efficacy in diabetes fell below expectations, analysts were encouraged by GSBR-1290’s clean safety and efficacy among obesity patients. ....
Structure Therapeutics diabetes pill missed market expectations for weight loss in a mid-stage trial and also fell short of results from a similar treatment from rival Eli Lilly, sending the biotech. ....
Structure Therapeutic obesity pill shows promise in mid-stage trial marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Structure Therapeutics (GPCR) Provides GSBR-1290 Program Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
GSBR-1290 was generally well-tolerated with no treatment-related serious adverse events over 12 weeks; 2.8% study discontinuation rate due to adverse events related to study drug in diabetes and 0%. ....